Data from primary CD45+ CD34+ CML blasts support this conclusion as they show that stroma increases mitochondrial dependence and non-glucose capacity in leukemia, while simultaneously decreasing glucose dependence and glycolytic capacity. This evidence concerns the gene PTPRC and chronic myelogenous leukemia, BCR-ABL1 positive.